Incidents have been reported of patients with a mechanical heart valve on anticoagulation with a vitamin K antagonist (VKA), usually warfarin, being switched to a LMWH or a DOAC.
This alert asks GPs and other NHS providers of anticoagulation services to identify any patients who have a record of a mechanical heart valve and are receiving a DOAC and to urgently review these patients to ensure they are on the most appropriate anticoagulation therapy and monitoring.
For action to be completed by 28 July 2021.
Read the alert
See the full article on the NHS website